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Objective: Despite the serious neurodevelopmental sequelae of epileptic encephalopathy during infancy, the pathomechanisms involved remain unclear. To find potential
biomarkers that can reflect the pathogenesis of epileptic encephalopathy, we explored
the neurometabolic and microstructural sequelae after infantile spasms using a rat model
of infantile spasms and in vivo magnetic resonance imaging techniques.
Methods: Rats prenatally exposed to betamethasone were subjected to three rounds
of intraperitoneal N-methyl-d-aspartate (NMDA) triggering of spasms or received saline
injections (controls) on postnatal days (P) 12, 13, and 15. Chemical exchange saturation
transfer imaging of glutamate (GluCEST) were performed at P15 and 22 and diffusion
tensor imaging and additional spectroscopy (1H-MRI/MRS) of the cingulate cortex were
serially done at P16, 23, and 30 and analyzed. Pathological analysis and western blotting
were performed with rats sacrificed on P35.
Results: Within 24 h of the three rounds of NMDA-induced spasms, there was an acute
increase in the GluCEST (%) in the cortex, hippocampus, and striatum. When focused on
the cingulate cortex, mean diffusivity (MD) was significantly decreased during the acute
period after multiple spasms with an increase in γ-aminobutyric acid (GABA), glutamate,
and glutamine N-acetylaspartate-plus-N-acetylaspartylglutamate (tNAA), total choline,
and total creatine. The juvenile rats also showed decreased MD on diffusion tensor imaging and significant decreases in taurine, tNAA, and macromolecules-plus-lipids in the
cingulate cortex. Pathologically, there was a significant reduction in glial fibrillary acidic
protein, myelin basic protein, and neuronal nuclei expression in the cingulate cortex of
rats with NMDA-induced spasms.
Significance: These neurometabolic and microstructural alterations after NMDAtriggered spasms might be potential imaging biomarkers of epileptic encephalopathy.
Keywords: infantile spasms, MR spectroscopy, neurometabolites, cingulate cortex, animal models
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INTRODUCTION

To add longitudinal in vivo data to this model, we adopted the
latest high-field proton MRI technologies including chemical
exchange saturation transfer imaging of glutamate (GluCEST),
diffusion tensor imaging, and spectroscopy (1H-MRI/MRS).
GluCEST imaging can map the level of glutamate in vivo at a high
spatial resolution (9–11), and diffusion tensor imaging is used
to reveal the in vivo connectivity of the nervous system (12, 13).
1
H-MRS allows noninvasive quantification of brain metabolites
in specific brain areas and has been successfully used in the field
of epilepsy research (14, 15). Specifically, the in vivo developmen
tal changes in neurometabolites and connectivity were measured
in the cingulate cortex, which has extensive connections with
critical regions such as the basal ganglia, thalamus, brainstem,
and hippocampus (16, 17). Additional histopathologic analyses
and behavioral tests were performed to further elucidate the
microstructural and neurochemical changes.

Infantile spasms are an epileptic encephalopathy that requires
urgent therapeutic intervention to avoid severe consequences,
such as mental retardation and developmental regression (1).
Diverse etiologies, including both unidentified causes and esta
blished brain pathologies, can lead to infantile spasms with diffuse
electrographic abnormalities (2), which probably impair common
developmental processes such as synaptogenesis, myelination,
and neuronal migration, causing mental retardation or refractory
epilepsies in later life (3, 4). However, these neurodevelopmental
consequences have not been clearly characterized (2).
To support the rationale for an aggressive treatment approach
for infantile spasms, it is crucial to determine the changes pro
duced by the spasms in the immature brain and assess the pos
sibility for a restoration or reversal of these changes. In children
with infantile spasms, evaluation of the effects of spasms on the
brain is extremely complicated because of ethical problems and
a relatively small number of patients with heterogeneous etiolo
gies (5) and treatment protocols (6, 7).
From the bench side, it would be advantageous to have a model
without pre-existing lesions and a model with easily operable
spasms to identify the pathological effects of the experimental
spasms on the brain. The rat model of N-methyl-d-aspartate
(NMDA)-triggered spasms (4) after prenatal betamethasone pri
ming is regarded as having a cryptogenic etiology and the spasms
are reliably triggered by the injection of NMDA. The NMDAtriggered spasms can be provoked at postnatal day 12–15, a
period in rodents relevant to human infancy (3, 4). The model
also displays several behavioral changes after multiple spasms (3),
corresponding to those of patients with infantile spasms, and has
recently been independently verified (8).
In the present study, using this rat model of NMDA-induced
infantile spasms, we performed MR imaging to evaluate the
acute and chronic neurometabolic and microstructural changes
after spasms as potential biomarkers of epileptic encephalopathy.

MATERIALS AND METHODS
Animals

Experiments were approved by the Institutional Animal Care
and Use Committee of the Ulsan University College of Medi
cine and conformed to the Revised Guide for the Care and
Use of Laboratory Animals [NIH GUIDE, 25(28), 1996] (18).
Timed-pregnant Sprague-Dawley rats were purchased from an
approved source (Orient Bio Inc., Seoul, Korea). The rats were
housed individually in the animal facility during the remainder
of their pregnancy with free access to standard rat chow and
water on a regular 12-h light-dark cycle with the lights on at
08:00. On gestational day 15, pregnant rats received two injections of
0.4 mg/kg betamethasone (Sigma-Aldrich, St. Louis, MO, USA)
at 08:30 and 18:30. Delivery occurred consistently on gestational
day 22, which was considered postnatal day (P) 0 for the offspring.
Spasms were triggered by intraperitoneal injection of NMDA
on P12 (6 mg/kg), P13 (10 mg/kg), and P15 (15 mg/kg); control
groups received the same volume of saline (Figure 1). Immediately

Figure 1 | Timeline of N-methyl-d-aspartate (NMDA)-induced spasms, MRI acquisition, behavioral tests, and tissue collection. IHC, immunohistochemistry;
WB, western blot.
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after NMDA administration, the rats were observed for 90 min
and only the animals confirmed to have had three bouts of spasms
at the appropriate time points on each day (i.e., on P12, P13,
and P15) were included in the analyses (4).

correction for B1 was calculated as the ratio of the actual B1 to the
expected value.
1
H-MRI/MRS images were obtained at the assigned times
as follows (Figure 1): (1) 1 day after the last cluster of spasms
(P16), (2) about 1 week after the spasms (P23), and (3) about
2 weeks after the spasms (P30). The MR spectra were acquired
through a signal voxel (from bregma to −3.0 mm in a coronal
section, 3 mm × 2 mm × 1.5 mm) in the cingulate cortex using a
point-resolved spectroscopy (PRESS) sequence for 128 acquisi
tions with TR/TE = 5,000/13.4 ms. For quantification, unsup
pressed water signals were also acquired from the same voxel
(average = 8). All the MR spectra were processed with the linear
combination analysis method (LC Model ver. 6.0, Los Angeles,
CA, USA) to calculate the metabolite concentrations from a fit to
the experimental spectrum, based on a simulated basis set. The
following brain metabolites were included in the metabolite basis
set: alanine (Ala), aspartate (Asp), creatine (Cr), γ-aminobutyric
acid (GABA), glucose (Glc), glutamate (Glu), glutamine (Gln),
glycerophosphorylcholine (GPC), phosphorylcholine (PCh),
myo-inositol (mIns), lactate (Lac), phosphocreatine (PCr),
N-acetylaspartate (NAA), N-acetylaspartylglutamate (NAAG),
taurine (Tau), macromolecules (MMs), and lipids (Lip). The
water-suppressed time domain data were analyzed between
0.2 and 4.0 ppm, without further T1 or T2 correction. Absolute
metabolite concentrations (mmol/kg wet weight) were calculated
using the unsuppressed water signal as an internal reference
(assuming 80% brain water content) (19). The in vivo proton
spectra were judged to have an acceptable value if the stand
ard deviation of the fit for the metabolite was less than 20%
(Cramer–Rao lower bounds). MR diffusion tensor images were
acquired using a four-shot DT-echo planar imaging sequence
(TR = 3.7 s, TE = 20 ms, B0 = 1,000 s/mm2) with a 10-ms inter
val (Δ) between the application of diffusion gradient pulses, a
4-ms diffusion gradient duration (δ), a gradient amplitude (G)
of 46.52 mT/m, and the Jones 30 gradient scheme.
Postprocessing analysis was performed using Diffusion Toolkit
software (http://trackvis.org/). The cingulate cortex of each rat
was selected and the fractional anisotropy (FA) and mean diffu
sivity (MD) were calculated from the diffusion tensor parametric
maps. Subsequently, repeated measures ANOVA and t-tests were
conducted to test for the treatment effect of the different diffusion
parameters.

MR Imaging Studies

Animals were maintained under anesthesia with 1% isoflurane
in a 1:2 mixture of O2:N2O with monitoring of their respiratory
rate, electrocardiogram, and rectal temperature. GluCEST MR
imaging was performed using a 7.0 T/160-mm small-animal
imaging system (Bruker Pharmascan, Ettlingen, Germany) with
a single-channel surface coil. Images were obtained using a 9.4
T/160-mm bore animal MRI system (Agilent Technologies,
Santa Clara, CA, USA) for 1H-MRS and diffusion tensor ima
ging. Radiofrequency excitation and signal detection were
accomplished with a 72-mm quadrature volume coil and a twochannel phased-array coil, respectively. Axial slices correspond
ing to coronal images in the neuroanatomic axis were collected
from the cervical spinal cord to the olfactory bulb.
GluCEST images were acquired from an axial slice (1-mm
thick) that included the hippocampal region. GluCEST images
were acquired using T2-weighted imaging (rapid acquisition
with relaxation enhancement [RARE]) with a frequency selective
saturation preparation pulse comprised a Gaussian pulse with
a total duration of 1,000 ms (irradiation offset of 500.0 Hz and
interpulse delay of 10 µs) at a B1 peak of 5.6 µT. Z-spectra were
obtained from −5.0 ppm to +5.0 ppm with intervals of 0.33 ppm
(total, 31 images, Figure S1 in Supplementary Material). The
sequence parameters were as follows: repetition time/echo time
(TR/TE) = 4,200/36.4 ms, field of view = 30 mm × 30 mm, slice
thickness = 1 mm, matrix size = 96 × 96, RARE factor = 16,
echo spacing = 6.066 ms, and average = 1. To confirm the linear
GluCEST effect, a phantom consisting of test tubes with different
concentrations of glutamate (pH 7.0) images at 7 T was also done
(Figure S2 in Supplementary Material).
To measure the GluCEST value (%), each region of interest
(cortex, hippocampus, striatum) was drawn manually on the T2weighted anatomical MR images without a frequency selective
saturation preparation pulse, and the regions of interest were
overlaid on the GluCEST maps. GluCEST contrast is measured
as the asymmetry between an image obtained with saturation at
the resonant frequency of exchangeable amine protons (+3 ppm
downfield from water for glutamate) and an image with satura
tion equidistant upfield from water (–3 ppm), according to the
following equation:
GluCEST(%) =

Behavioral Testing

After NMDA-induced spasms, rats performed an open-field
test on P19 and fear conditioning tests on P27–29 (Figure 1).
Behavioral experiments were conducted in a standard behavioral
testing room during the light phase (08:00–20:00 h) of a regular
12-h light–dark cycle.

S−3.0 ppm − S+3.0 ppm
* 100
S−3.0 ppm

where S−3.0ppm and S+3.0ppm are the magnetizations obtained with
saturation at a specified offset from the water resonance of
4.7 ppm.
The B0/B1 maps on the same slices were acquired for B0 and
B1 correction. The B0 map was calculated by linearly fitting the
accumulated phase per pixel following phase unwrapping against
the echo time differences from gradient echo images collected
at TEs of =1.9 and 2.6 ms. B1 maps were calculated by using the
double-angle method (flip angles 30° and 60°) and the linear
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Open-Field Test

The locomotive activity of controls and rats after NMDAtriggered spasms was assessed using an open-field test as previ
ously described (20). Rats were placed into a black plastic box
(60 cm × 60 cm2 field with a 30-cm high perimeter) for 5 min,
and their activities were monitored (3, 21) using computerized
motion-tracking software (SMART 3.0; Panlab S.L.U., Barcelona,
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Spain). The center was defined as the middle area 10 cm apart
from each wall and the other area was defined as the periphery
(i.e., 2,000 cm2 periphery and 1,600 cm2 center; allocation of the
area = 5:4).

MBP. Three or five randomly selected areas (1.0 × 104 sq μm) on
each section were used for NeuN- and GFAP-positive cell count
ing. The same areas of binarized images of MBP-stained sections
were quantified from each animal.

Fear Conditioning

Western Blot Analysis

After deep anesthesia, bilateral cortical tissues from bregma to
the posterior hippocampal area without the hippocampus (ante
rior posterior 0 to −5 mm) were collected from controls and
rats with NMDA-triggered spasms on P35. Anti-MBP (1:2,000;
Santa Cruz Biotechnology, Inc.), anti-NeuN (1:5,000; EMD
Millipore), or anti-GFAP (1:5,000; EMD Millipore) antibodies
were used. Normalization was performed by the development of
parallel western blots probed with β-actin (1:20,000; Santa Cruz
Biotechnology Inc.) antibody analyzed by densitometry using
ImageJ software (NIH, Bethesda, MD).

The observation chamber (25 cm × 25 cm × 25 cm; Panlab s.l.u.)
was constructed of aluminum (two side walls and ceiling) and
Plexiglas (rear wall and hinged front door) and was situated in a
soundproof box. The floor of the chamber consisted of 19 stainless
steel rods (4 mm diameter) spaced 1.6 cm apart (center to center),
which were connected to a shock generator and grid scrambler
(Panlab s.l.u.). A tone (conditioned stimulus) was delivered by
a speaker mounted on one side panel of the chamber and both
the shock and tone deliveries were controlled by a computerized
system.
Tone conditioning was conducted on P27. Modified from
a previous report (22), the conditioning consisted of a 3-min
baseline habituation in the experimental chambers, followed by
exposure to five pairings of a tone (conditioned stimulus; 30 s,
85 dB, 2,000 Hz) with white-light illumination, each ending
with a final footshock (unconditioned stimulus; 0.8 mA, 2.0 s)
followed by a 20-s silent interval. Response to the context was
monitored on P28 (24 h after the conditioning trial). The rats
were returned to the chamber for 5 min, and freezing behavior
was measured in response to the context. Fear response to the
conditioned stimulus was conducted at 24 h after the contextual
fear testing (P29). To reduce the influence of context on cued
fear conditioning, tactile and visual cues were manipulated with
the replacement of a wall and a floor. Following a 2-min period
without a conditioned stimulus (first session, unconditioned),
the rats were presented with five tone parings (85 dB, 2 kHz,
30 s, session Nos. 2, 4, 6, 8, and 10; 20 s between tone presenta
tions, session Nos. 3, 5, 7, 9, and 11) without any foot shock.
The behaviors of the rats were recorded and analyzed using the
signal generated by a high-sensitivity weight transducer system
(Panlab s.l.u.).

Statistics

The Mann–Whitney’s U test was used for the comparison of
two groups and Student’s t-test was used for the data following
normal distribution. The concentrations of metabolites were
compared between the groups and time points using a linear
mixed model. The absence of significant sex-based differences
(p always > 0.10) was confirmed in advance, and both sexes were
combined. The significance level was preset to p < 0.05. Statistical
analyses were conducted using SAS® Version 9.3 (SAS Institute
Inc., Cary, NC, USA) and SPSS 18.0 (IBM Corp., Armonk,
NY, USA).

RESULTS
Mapping of the Glutamate Concentration
at Acute Periods After Three Rounds
of NMDA Spasms

There were significant increases in the GluCEST (%) levels of rats
with three rounds of NMDA-induced spasms in the cortex and
hippocampus at P15 (N = 14; cortex, 13.20 ± 0.74%, p = 0.011;
hippocampus, 12.36 ± 0.91%, p = 0.016; striatum, 10.10 ± 0.96%,
p = 0.062) compared with controls (N = 14, 9.71 ± 0.82%,
9.32 ± 0.81%, 7.23 ± 1.00% in each area). There was a develop
mental increase in the GluCEST (%) at P22 but no significant
difference in the GluCEST (%) between the rats with spasms and
controls (Figure 2).

Sample Preparation and
Immunohistochemistry

The animals with three bouts of spasms on P12, P13, and P15 and
the corresponding controls were transcardially perfused with
4% paraformaldehyde on P35 under deep anesthesia, and their
brains were removed and cryoprotected. Twenty-micron serial
coronal sections were cut on a cryocut microtome.
For immunohistochemistry, myelin basic protein (MBP) anti
body (1:1,000; Santa Cruz Biotechnology, Inc., Santa Cruz, CA,
USA), glial fibrillary acidic protein (GFAP) antibody (1:2,000;
EMD Millipore, Billerica, MA, USA), or neuronal nuclei (NeuN)
antibody (1:2,000; EMD Millipore) were used as primary anti
bodies. All slides were examined by light microscopy (Olympus
BX-53; Olympus Co., Tokyo, Japan). Semi-quantification analysis
of immunohistochemical staining was performed using ImageJ
(NIH, Bethesda, MD). The corresponding area in the cingulate
cortex cg2 subfield was analyzed to determine the NeuN- and
GFAP-positive cell count and the stained area measurement of

Frontiers in Neurology | www.frontiersin.org

Neurochemical Alterations in the
Cingulate Cortex After Multiple
NMDA-Triggered Spasms

There was no significant morphological difference between the two
groups (NMDA-induced spasms [n = 12] and controls [n = 10])
on visual evaluation of serial T2-weighted MR images. One day
after the last NMDA injection (P16), GABA (p = 0.008), Glx
(Glu + Gln, p = 0.024), tNAA (p = 0.006), tCho (p = 0.014),
and tCr (p = 0.007) levels measured from cingulate cortex
(Figure 3A) were significantly increased in rats with NMDAinduced spasms (Figures 3B,E,G,H). At 1 week (P23) after the
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Behavioral Changes After Multiple
Bouts of NMDA-Triggered Spasms

To evaluate the behavioral changes that occurred after multiple
bouts of NMDA-induced spasms, the results of open-field and
fear conditioning tests were compared between the rats that
had experienced three bouts of NMDA-triggered spasms and
controls. In the open-field test on P19, the rats with NMDAinduced spasms (n = 23) traveled a significantly shorter distance
through the peripheral area (p = 0.005) as well as in the total area
(p = 0.006) compared with controls (n = 20; Figure 5A). Resting
time in the peripheral area was significantly increased in rats with
NMDA-induced spasms (p = 0.012) compared with controls. The
time spent in slow and fast motion in the peripheral area was
significantly decreased in the rats with NMDA-induced spasms
compared with controls (p = 0.014 and p = 0.010, respectively;
Figure 5B). The time spent in the center was equivalent in the
two groups.
In fear conditioning tests on P27–29, there was no difference in
tone conditioning on P27 or response to context on P28. However,
on P29, the total freezing durations were significantly increased
in rats with NMDA-induced spasms compared with controls
(p = 0.037; Figure 5C). During the first session, freezing durations
were not different between the two groups (p = 0.058), but freez
ing durations were significantly increased in rats with NMDAinduced spasms at conditioned sessions from 6 to 9, in particular
(p = 0.007, 0.002, 0.047, and 0.022, respectively; Figure 5D).

Figure 2 | (A) After three rounds of spasms on postnatal day (P) 12, 13,
and 15, glutamate chemical exchange saturation transfer (GluCEST, %) levels
were measured in the cortex, hippocampus, and striatum on P15. (B) There
were significant increases in the GluCEST (%) of rats with three rounds of
N-methyl-d-aspartate (NMDA)-induced spasms compared with controls in
all measured areas. A developmental increase in the GluCEST (%) from P15
to P22 was noted, and there was no significant difference in the GluCEST
(%) between rats with spasms and controls.

Reduced GFAP, MBP, and NeuN
Expression in the Juvenile Period
After Multiple Bouts of NMDATriggered Spasms

NMDA-induced spasms, there were also no significant differ
ences in the concentrations of the neurochemicals measured
in the cingulate cortex between the two groups. At 2 weeks
(P30) after the NMDA-induced spasms, Tau (p = 0.016), tNAA
(p = 0.026), and MM + Lips (p = 0.042) were significantly
decreased compared with controls (P30; Figures 3D–F). The
temporal changes in each neurometabolite were compared
between the groups, and glutamine and glutamate (Glx,
F = 3.30, DF1 = 2, DF2 = 34.7, p = 0.049), Tau (F = 10.52,
DF1 = 2, DF2 = 32.5, p < 0.001), tNAA (NAA + NAAG, F = 6.57,
DF1 = 2, DF2 = 15.7, p = 0.008), MMs and lipids (MM + Lips,
F = 4.01, DF1 = 2, DF2 = 15.4, p = 0.039), and total choline
(tCho, p = 0.006) were significantly different between the two
groups (Figures 3C–G).

Semi-quantitative analysis of immunohistochemical staining on
P35 revealed a significant reduction in NeuN- and GFAP-positive
cells (both p < 0.001) and MBP-positive area (p = 0.041) in rats
with three bouts of NMDA-triggered spasms (on P12, P13, and
P15, n = 13) compared with controls (n = 11) (Figure 6). The
cortical protein expression levels of GFAP, MBP, and NeuN on
P35 were quantified and compared between the rats with multiple
spasms and controls. GFAP (p = 0.007), MBP (p = 0.027), and
NeuN (p = 0.001) expression was significantly reduced in the
cortex of rats with NMDA-induced spasms (n = 13) compared
with controls (n = 13; Figure 6).

DISCUSSION
In Vivo Microstructural Alterations
Following Multiple Bouts of NMDATriggered Spasms

An early diagnosis of infantile spasms has been considered criti
cal for improving the neurodevelopmental outcomes of affected
patients (23). However, it is uncertain which part of the developing
brain is affected by infantile spasms, as is the extent of any brain
insult and whether it is reversible. Our present study focused on
metabolic and microstructural brain insults after spasms in a rat
model of infantile spasms using in vivo MR imaging. Behavioral
tests and ex vivo histopathological processes were employed to
support the results.
Considering the increased metabolism of brain tissue dur
ing seizures, neurochemical dysfunction might be the main

There was no significant difference in the FA values at each time
point between rats with spasms (N = 15) and controls (N = 15).
The rats with multiple bouts of NMDA-triggered spasms showed
a significantly decreased MD at P16 and P30 in both cingulate
cortices (right/left cingulate cortex: P16, 6.64 × 10−4/6.59 × 10−4,
p = 0.012/p = 0.001; P30, 6.05 × 10−4/6.14 × 10−4; p = 0.036/p = 0.016)
compared with controls (P16, 7.01 × 10−4/7.06 × 10−4; P30,
6.48 × 10−4/6.74 × 10−4, Figure 4).
Frontiers in Neurology | www.frontiersin.org
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Figure 3 | Neurochemical changes in rats with N-methyl-d-aspartate (NMDA)-induced spasms using 1H-MRS findings. (A) A single voxel position in the cingulate
cortex (top, coronal section; bottom, horizontal section). The brain levels of GABA, glutamine + glutamate (Glx), tNAA, total choline, and tCr were significantly
higher in rats with NMDA-induced spasms on P16 (B,C,E,G,H). (D–F) At 2 weeks, taurine (Tau), tNAA, and macromolecules + lipids (MM + lipids) were significantly
decreased in rats with spasms. (C–G) The changes in Glx, Tau, tNAA, MM + lipids, and total choline with time were significantly different between the groups.
(I) The examples of MR spectra from rats with or without 3 NMDA spasms on each time points, P16 and P30 clearly shows the neurometabolic changes after
NMDA-induced spasms. *indicates a significant difference between the groups at each time point (p < 0.05). Using a generalized linear mixed model, there were
also significantly different interactions between the groups and time points for Glx, Tau, tNAA, MM + lipids, and total choline (each p-value is marked on the graph).
All imaging was done on the same timepoints (P16, 23, and 30), although the data points are not aligned across groups to avoid overlapping of the two graphs.

Frontiers in Neurology | www.frontiersin.org
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Figure 4 | (A) On diffusion tensor imaging of rats after N-methyl-d-aspartate (NMDA)-induced spasms and controls, fractional anisotropy (FA) and mean diffusivity
(MD) were measured in the cingulate cortex of each animal. (B) The anatomical location of cingulate cortex was clearly identified on FA/MD maps of the rat at P16.
(C) There were no significant differences in the FA values at each time point between the rats with spasms (N = 15) and controls (N = 15). Rats with multiple bouts
of NMDA-triggered spasms showed a significantly decreased MD at P16 and P30 in both cingulate cortices compared with controls.

Frontiers in Neurology | www.frontiersin.org
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Figure 5 | Comparison of behavioral changes between rats with N-methyl-d-aspartate (NMDA)-induced spasms and controls. (A,B) Open-field test showing
significantly decreased exploration distances in rats with NMDA-induced spasms in peripheral and total areas (A) and significantly increased resting activities and
decreased slow and fast activities in the peripheral area (B) of rats with spasms. The rats with NMDA-induced spasms also showed significantly increased durations
of freezing to sound and light stimuli (C) that persisted after several sessions without shocks (D) in a fear conditioning test. There was a significant difference in
freezing durations between the two groups. *indicates a significant difference between the groups (*p < 0.05, Mann–Whitney U test).

pathophysiologic feature of the epileptic brain (24), especially
during the acute stage. The GluCEST technique quantifies gluta
mate by measuring proton exchange between the amine protons
of the glutamate and the water protons and the measurement
is at least 100 times more sensitive than the traditional 1H
MRS method (9, 25). The GluCEST is suggested as a surrogate
marker of glutamate concentration in glial cells at the synaptic
level (25) and glutamate contributes >90% of the GluCEST
signal with <10% contribution from other metabolites in glial
neuronal unit (10). Previous study with temporal lobe epilepsy
patients also showed the high potential of GluCEST identifying
the epileptogenic foci (26). Thus, we hypothesized that the area
of hyperexcitation in rats with NMDA-induced spasms can be
screened with GluCEST imaging with high spatial resolution
during acute periods. GluCEST mapping showed significantly
increased glutamate in cortex and hippocampus at P15 after
multiple rounds of spasms (Figure 2), which suggests that the
cortex is one of the major brain area of hyperexcitation by the
NMDA-induced spasms.
Our in vivo serial neurochemical/microstructural analysis
focused on the cingulate cortex in the rat after multiple bouts
of spasms. The cingulate cortex is a region of the limbic system
reciprocally linked to the hippocampus (17) and with extensive
Frontiers in Neurology | www.frontiersin.org

connections to the critical regions for spasm generation, includ
ing the basal ganglia, thalamus, and brainstem (16, 27). In the
cingulate cortex, consistent with the findings of GluCEST imag
ing, acute elevations in GABA, Glx, tNAA, tCho, and tCr were
noted in rats after multiple bouts of NMDA-induced spasms
compared with controls (Figure 3). The glutamate plus glutamine
levels likely represent the neuronal metabolic pool. In vivo human
proton MRS studies (28, 29) have also reported alterations in
GABA and glutamate in patients with epilepsy. In addition,
choline (Cho) represents a precursor for the neurotransmitter
acetylcholine (30) and creatinine is associated with energy
metabolism (31, 32). The early elevation of markers of neuronal
metabolism together with the excitatory neurotransmitters in the
cingulate cortex may also reflect activation of the cingulate cortex
during NMDA-induced spasms in this model.
With diffusion tensor imaging, we also identified an acute
decrease in MD in the cingulate cortex after three bouts of spasms,
which represent the early brain damage (33). MD is an inverse
measure of the membrane density, is sensitive to cellularity,
edema, and necrosis (34). MD decrease quickly after injury (first
day) in most models studied, which is consistent with our find
ing at P16. The decrease was explained by the decrease in water
diffusion associated with injury such as cellular edema, despite
8
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Figure 6 | Glial fibrillary acidic protein (GFAP), myelin basic protein (MBP), and neuronal nuclei (NeuN) expression in the cingulate cortex during the juvenile period.
(Left) Immunohistochemical staining of the cingulate cortex on P35 revealed decreased expression of GFAP, MBP, and NeuN in rats with three bouts of N-methyl-daspartate (NMDA)-induced spasms. The scale bars indicate 50 µm. (Right) Western blot analysis of the rat cortex on P35 showed significantly decreased expression
of GFAP, MBP, and NeuN after multiple bouts of NMDA-induced spasms (*p < 0.05, Mann–Whitney U test).

there is still debate on the precise mechanism for the decrease in
MD associated with injury. Previously postictal decrease of MD
was reported in human (35), which is consistent with our finding
and probably reflects neuronal swelling by excitotoxic injury in
the brain areas involved in seizure.
In addition to these acute changes associated with spasms,
in vivo MR imaging enables us to perform a longitudinal followup of neurometabolic and microstructural alterations in rats
with NMDA-triggered spasms. NMDA is an excitatory amino
acid that can cause neuronal death and glial activation is well
observed in kainic acid animal model and tissues of patients with
chronic epilepsy (36). However, gross morphological changes
caused by NMDA-induced spasms in our model were not
evident on brain MR imaging and a previous pathologic report
of NMDA-induced seizures in young animals also reported no
gross morphological changes on pathology (37). Consistently
with this finding, FA, a gross measure of microstructural integ
rity marker that is less specific to the type of injury (33), is not
affected in every time point of this study.
In the cingulate cortices of the juvenile rats with NMDAinduced spasms (P30), tNAA, Tau, and MM + lipids were sig
nificantly decreased with a significant reduction in MD. We also
found decreased expression of neuronal, astrocyte, and myelina
tion markers after NMDA-induced spasms in these rats. These

Frontiers in Neurology | www.frontiersin.org

findings suggest the different mechanism of injury during infancy
compared to that of the adulthood. Instead of cell death or gliosis
after excitatory injury, the developmental process of their brain,
active protein synthesis and cell proliferation, may be involved.
These pathologic changes are also in line with a significant reduc
tion in neuronal markers, NAA, and Tau and markers of myelin
production and substructural components such as MMs and
lipids (31, 38), as well as the reduced MD reflecting decreased
membrane density and cellularity (34, 39).
Previous research into epilepsy has already shown the typi
cal developmental pattern of neurometabolites in both a rodent
model (40) and in humans (32). NMDA-triggered spasms signifi
cantly impaired this time-dependent neurometabolic develop
mental pattern of Glx, Tau, tNAA, MM + lipids, and total choline
(Figure 3). These combined alterations in neurometabolites and
structural maturation markers in this animal model indicate
the compromised development of the cingulate cortex follow
ing NMDA-triggered spasms. Also, the decrease of all proteins
examined can be explained by a decrease in protein synthesis
during the critical brain development after NMDA-triggered
spasms.
Furthermore, decreased exploratory behaviors in the periph
eral areas and increased freezing activities to conditioned sound
and light stimuli were also observed in our study group that

9
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suffered from NMDA-induced spasms. Other behavioral disrup
tions were found in previous studies with similar models (21, 37).
Considering the widespread reduction in neuronal metabolites
in neurodevelopmental disorders (31) and a positive correlation
between motor skill learning and myelination (41), the pathologi
cal changes in the brain might explain these behavioral changes.
In conclusion, NMDA-induced spasms during infancy lead to
time-dependent neurochemical and microstructural changes in
the cingulate cortex and subsequent pathologic changes during
the juvenile period. These age-dependent alterations in neuro
metabolites after NMDA-triggered spasms should be further
explored as potential biomarkers of outcomes in human infantile
spasms or other epileptic encephalopathies.
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